Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Vildan Kayku Liv Hospital Bahçeşehir Spec. MD. Vildan Kayku Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Squamous Carcinoma Lung: 8 Key Facts on Symptoms, Risks, and Treatments
Squamous Carcinoma Lung: 8 Key Facts on Symptoms, Risks, and Treatments 2

At Liv Hospital, we know how worrying it is when you have a cough that won’t go away or chest pain. These signs might mean you have squamous cell carcinoma in the lungs. This is a serious type of lung cancer.

Recent studies have made big steps in fighting cancer, including lung cancer. Immunotherapy and targeted therapies are key. We at Liv Hospital are all about giving top-notch care to patients from around the world.

It’s important to know about the symptoms, risks, and treatments for carcinoma in lungs. We’re here to offer hope and support. Our care is focused on you, the patient.

Key Takeaways

  • Understanding squamous carcinoma lung is key for early treatment.
  • Symptoms like a cough or chest pain can signal lung cancer.
  • Immunotherapy and targeted therapies have made big strides in cancer treatment.
  • Liv Hospital offers full care and advanced treatments for international patients.
  • Our care is all about you, focusing on treating carcinoma in lungs.

What Is Squamous Carcinoma Lung?

squamous carcinoma lung
Squamous Carcinoma Lung: 8 Key Facts on Symptoms, Risks, and Treatments 3

Squamous cell carcinoma of the lung is a common type of lung cancer. It’s often linked to smoking. It’s a big part of non-small cell lung cancer (NSCLC), which is the main type of lung cancer.

Definition and Classification

Squamous carcinoma lung starts in the squamous cells of the airways. It’s called non-small cell lung cancer because it’s different from small cell lung cancer. This difference is key for choosing the right treatment.

It’s a big part of NSCLC, along with adenocarcinoma and large cell carcinoma. The treatment for NSCLC, including squamous cell carcinoma, usually includes surgery, radiation, and chemotherapy.

Prevalence and Statistics

About 25-30% of lung cancer cases are squamous cell carcinoma. Research shows that the right treatment can greatly improve survival rates for NSCLC patients. Smoking history is a big factor in getting this cancer.

Statistics on squamous carcinoma lung vary worldwide. Places with more smokers tend to have more cases of this cancer. Knowing these numbers helps in fighting lung cancer.

Distinguishing Features of Squamous Cell Lung Cancer

A detailed, cross-sectional view of a squamous cell lung carcinoma, capturing its distinctive architectural and cellular features. The tumor mass occupies the central foreground, with irregular, proliferating nests of atypical squamous epithelial cells exhibiting abnormal keratinization and pleomorphism. The middle ground reveals the malignant cells infiltrating the surrounding alveolar and bronchial structures, disrupting the normal lung parenchyma. The background showcases the overall pulmonary anatomy, with the bronchioles and alveoli providing context. The lighting is crisp and evenly distributed, allowing for clear visualization of the pathological changes. The depth of field is moderate, ensuring focus on the key diagnostic features while maintaining peripheral context. The overall tone is one of clinical precision, highlighting the distinct morphological characteristics of squamous cell lung carcinoma.
Squamous Carcinoma Lung: 8 Key Facts on Symptoms, Risks, and Treatments 4

It’s important to know the unique signs of squamous cell lung cancer for better treatment. This type of lung cancer has special traits that set it apart from others.

Anatomical Location in Central Bronchi

Squamous cell lung cancer starts in the central bronchi. This is a key sign. Symptoms like persistent cough, blood in sputum, and chest pain can happen as the tumor grows. Recurring bronchitis or pneumonia may also occur due to the tumor blocking the airway.

Cellular Characteristics

The cells of squamous cell lung cancer are special. They show keratinization and intercellular bridges under a microscope. These signs help doctors diagnose squamous cell carcinoma and tell it apart from other lung cancers.

Comparison with Other Lung Cancer Types

Comparing squamous cell lung carcinoma to other lung cancers shows clear differences. Unlike adenocarcinoma, which starts in smaller airways, squamous cell carcinoma happens in the central airways. It’s also closely linked to smoking, more than other lung cancers. Knowing these differences helps doctors choose the right treatment, as each type responds differently to therapy.

Understanding these unique features helps us diagnose and treat squamous cell lung cancer better. Our team is here to help patients through every step, providing the care and support they need.

Major Risk Factors for Developing Squamous Carcinoma Lung

It’s important to know the risk factors for squamous carcinoma lung to prevent and catch it early. We’ll talk about the main risk factors. These include lifestyle, environmental, and genetic factors that can lead to this cancer.

Tobacco Use and Smoking History

Tobacco use is the biggest risk for squamous carcinoma lung. Research shows smoking causes 80-90% of lung cancer deaths. The more and harder you smoke, the higher your risk.

Being around secondhand smoke also raises the risk, but not as much as smoking yourself.

Environmental and Occupational Exposures

Some environmental and job exposures are big risks for squamous carcinoma lung. These include asbestos, radon, arsenic, and other harmful substances. People working in mining, construction, and manufacturing are at higher risk.

We stress the need to follow safety rules and laws to lower exposure.

Genetic and Demographic Factors

Genetic and demographic factors also affect the risk of squamous carcinoma lung. Family history, genetic mutations, and certain traits can increase risk. We help patients understand their risk by doing detailed assessments and counseling.

Knowing these risk factors helps people take steps to prevent and catch cancer early. We urge those at high risk to talk to their doctor. This way, they can make a plan to lower their risk of squamous carcinoma lung.

Recognizing Squamous Lung Cancer Symptoms

Spotting squamous lung cancer early is key. Its symptoms can be tricky to spot and might seem like other issues. Knowing these symptoms early can really help with treatment.

Early Warning Signs

The first signs of squamous lung cancer are often small. You might notice a persistent cough, blood in sputum, or chest pain. These can be easy to miss, so it’s important to watch out for them.

Other signs include bronchitis or pneumonia that keeps coming back, hoarseness, and unexplained weight loss. If these happen a lot or get worse, see a doctor right away.

“The earlier lung cancer is detected, the better the chances for successful treatment,” a principle that highlights the need to know these signs.

Advanced Symptom Presentation

As squamous lung cancer gets worse, symptoms get more serious. You might feel severe chest pain, difficulty swallowing, or swelling in the face and neck. This is because the tumor is pressing on nearby areas.

Advanced squamous lung cancer can also spread to other parts of the body. This can cause symptoms in places like the bones, brain, or liver.

When to Seek Medical Attention

If you have any of these symptoms, see a doctor, even if you’ve smoked before. Early tests and biopsies can help plan your treatment better.

Don’t hesitate to talk to a healthcare professional if your symptoms don’t go away or get worse. Our team is here to help you every step of the way.

Comprehensive Diagnosis Process

We use advanced imaging and careful biopsy procedures to diagnose squamous carcinoma lung. This detailed process is key for planning treatment. It ensures we get an accurate diagnosis.

Initial Screening and Imaging Techniques

Our first step is imaging. We use CT scans and PET scans to see the lungs and find any issues.

Imaging Techniques Used:

  • CT scans: Give detailed images of the lungs.
  • PET scans: Show if cancer has spread.
  • Chest X-rays: Used as a first check.

Biopsy Procedures and Pathology

After finding issues, we do biopsies to confirm. This involves taking tissue samples for lab tests.

Biopsy Methods:

  • Needle biopsy: A small, less invasive way to get tissue.
  • Bronchoscopy: Lets us see inside and take samples.
  • Surgical biopsy: Needed if other methods don’t work.

Lab tests on the biopsy sample are key. They confirm squamous cell carcinoma and its type.

Staging and Classification Systems

After confirming the diagnosis, we use staging systems. The TNM system is common. It looks at the tumor size, lymph node involvement, and if cancer has spread.

StageDescription5-Year Survival Rate
ICancer is localized to the lungs60-80%
IICancer has spread to nearby lymph nodes30-50%
IIICancer has spread to more distant lymph nodes or structures10-30%
IVCancer has metastasized to distant organs

For more on lung cancer prognosis and treatment, visit our page on whether lung cancer can be cured.

Treatment Options for Squamous Carcinoma Lung

Treatment for squamous carcinoma lung cancer includes a mix of therapies. We tailor plans to fit each patient’s needs. Our goal is to create effective strategies for each unique situation.

Surgical Approaches

Surgery is key for early-stage squamous cell carcinoma lung cancer. We offer several surgical options:

  • Lobectomy: removal of the lobe with the tumor
  • Sleeve resection: removing the tumor and part of the airway
  • Pneumonectomy: removing the whole lung in some cases

Radiation Therapy Modalities

Radiation therapy is also vital for squamous carcinoma lung. We use advanced techniques like:

  • 3D conformal radiation therapy
  • Intensity-modulated radiation therapy (IMRT)
  • Stereotactic body radiation therapy (SBRT) for early-stage disease

Chemotherapy Protocols

Chemotherapy is often used with other treatments for squamous carcinoma lung. Our chemotherapy aims to:

  • Shrink tumors before surgery or radiation
  • Control symptoms in advanced disease
  • Make other treatments more effective

Immunotherapy and Targeted Therapies

New advancements in immunotherapy and targeted therapies are promising. We offer:

  • Checkpoint inhibitors to boost the immune system’s response
  • Targeted therapies that focus on specific genetic mutations

We are dedicated to providing top-notch care for squamous carcinoma lung patients. We use the latest treatments and technologies.

Managing Advanced and Metastatic Disease

When squamous cell carcinoma lung reaches Stage IV, we focus on improving quality of life. At this stage, the cancer has spread far, making it hard to cure. We aim to manage symptoms and improve patient outcomes.

Treatment Strategies for Stage IV Disease

Stage IV squamous cell carcinoma lung needs a detailed treatment plan. We look at the patient’s health, how far the cancer has spread, and genetic mutations. Treatment options may include:

  • Systemic therapies like chemotherapy and immunotherapy to control cancer growth
  • Targeted therapies for specific genetic mutations
  • Palliative radiation therapy to alleviate symptoms

Palliative Care and Symptom Management

Palliative care is key for managing symptoms and improving quality of life in advanced cancer. We address physical, emotional, and social needs for full support. Common symptoms we manage include:

  • Pain: Using a combination of medications and other interventions to control pain effectively
  • Shortness of breath: Implementing oxygen therapy and other respiratory support measures
  • Nutritional challenges: Providing dietary guidance and support to maintain strength and overall health

Advanced disease can cause bone pain, headaches, or other neurological symptoms. We work with patients and their families to create a care plan. This plan addresses these challenges and improves overall well-being.

By adding palliative care to the treatment plan, we can greatly improve the quality of life for patients with advanced and metastatic squamous cell carcinoma lung. Our goal is to provide compassionate, complete care that supports patients on their journey.

Prognosis and Survival Considerations

Knowing the prognosis for squamous cell carcinoma lung is key for patients and their families. It helps them make informed decisions about their care. Prognosis is about the likely outcome of the disease, influenced by several factors.

Factors Affecting Prognosis

The prognosis for squamous carcinoma lung is influenced by several factors. These include the cancer’s stage at diagnosis, the patient’s overall health, and how well they respond to treatment. Early-stage diagnosis significantly improves survival chances. We also look at the patient’s age, smoking history, and any other health conditions.

FactorInfluence on Prognosis
Cancer StageEarly stages have better prognosis
Overall HealthPatients with fewer comorbidities fare better
Response to TreatmentPositive response improves survival

Five-Year Survival Statistics by Stage

Five-year survival statistics change a lot based on the cancer’s stage at diagnosis. We share these statistics to give patients a general idea of what to expect.

Stage at DiagnosisFive-Year Survival Rate
Stage I50-60%
Stage II30-40%
Stage III15-30%
Stage IVLess than 10%

These statistics are based on general data and may not reflect individual circumstances.

Quality of Life During and After Treatment

Keeping quality of life high is a big part of cancer care. We focus on treating the cancer and supporting patients through treatment and beyond. This includes managing symptoms, addressing side effects, and providing emotional and psychological support.

By understanding the factors that influence prognosis and survival rates, patients can better navigate their treatment journey. We are committed to providing care that addresses all aspects of a patient’s health and well-being.

Conclusion: Navigating Life After Diagnosis

Getting a diagnosis of squamous carcinoma lung can feel scary. But, with the right help and resources, patients can face their journey with hope. We know how important it is to support those living with squamous cell carcinoma lung. We offer detailed care to meet each patient’s needs.

We are committed to top-notch healthcare. This includes support for squamous carcinoma lung through many ways. Our team works hard to ensure patients get the best care from start to finish. We also help patients find valuable lung cancer resources, so they can make smart health choices.

With our help and support, patients can manage their condition better. This improves their life quality. We aim to help patients deal with lung cancer’s challenges. We create a supportive space that encourages hope and strength.3

What is squamous carcinoma lung?

Squamous carcinoma lung is a type of lung cancer. It starts in the squamous cells. These cells line the airways in the lungs.

Is squamous cell lung cancer the same as non-small cell lung cancer?

Yes, squamous cell lung cancer is a part of non-small cell lung cancer (NSCLC). NSCLC makes up about 85% of lung cancers. Squamous cell carcinoma is one of its main types.

What are the major risk factors for developing squamous carcinoma lung?

Main risks include smoking and using tobacco. Exposure to harmful substances like asbestos and radon also increases risk. Genetic and demographic factors play a role too.

What are the common symptoms of squamous lung cancer?

Symptoms include coughing and chest pain. Coughing up blood or rust-colored sputum is common. Shortness of breath and wheezing are also symptoms. As the disease gets worse, new symptoms may appear.

How is squamous carcinoma lung diagnosed?

First, doctors use chest X-rays and CT scans for screening. Then, a biopsy is done to check for cancer cells. The disease’s extent is determined using staging and classification systems.

What are the treatment options for squamous carcinoma lung?

Treatments include surgery, radiation, and chemotherapy. Immunotherapy and targeted therapies are also used. The choice depends on the disease’s stage and the patient’s needs.

Can squamous cell lung cancer be treated if it’s diagnosed at an advanced stage?

Yes, treatment is possible even at an advanced stage. For stage IV, treatments aim to control symptoms and slow disease progression. This improves quality of life through palliative care.

What is the prognosis for squamous carcinoma lung?

Prognosis varies based on several factors. These include the disease’s stage, overall health, and treatment response. Our team offers support to improve life quality during and after treatment.

How can patients navigate life after a diagnosis of squamous carcinoma lung?

Patients can work with our team to create a personalized treatment plan. They can also access support services and stay informed about their condition and treatment options.

Is squamous cell carcinoma of the lung related to smoking?

Yes, it is strongly linked to tobacco use and smoking history. Smoking causes about 80-90% of lung cancer deaths.

What is the difference between squamous cell carcinoma and other types of lung cancer?

Squamous cell carcinoma is different due to its cellular characteristics and location. It usually starts in the central bronchi. It differs from adenocarcinoma and small cell lung cancer in these aspects.

Reference

Lung Cancer Foundation of America (LCFA). Squamous Cell Carcinomas. https://lcfamerica.org/about-lung-cancer/diagnosis/types/squamous-cell-carcinomas/

NCBI. Research. https://www.ncbi.nlm.nih.gov/books/NBK564510/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Vildan Kayku Medical Oncology

Spec. MD. Vildan Kayku

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 28 17